US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Beta Bionics, Inc.

19.08

-0.4700-2.40%

Post-market: 19.080.00000.00%19:48 EDT

Volume:583.62K

Turnover:11.23M

Market Cap:827.24M

PE:-3.37

High:20.19

Open:19.96

Low:18.35

Close:19.55

Loading ...

Overview Company News Filings

Chief Commercial Officer Mark Hopman Reports Disposal of Common Shares of Beta Bionics Inc

CFO Stephen Feider Reports Disposal of Beta Bionics Inc. Common Shares

Beta Bionics Initiated at Outperform by Wolfe Research

Beta Bionics initiated with a Neutral at Goldman Sachs

Beta Bionics initiated with an Outperform at Wolfe Research

Beta Bionics reports Q1 EPS (93c), consensus (51c)

Beta Bionics raises FY25 revenue view to $82M-$87M from $80M-$85M

Beta Bionics Q1 EPS $(0.93) Misses $(0.46) Estimate, Sales $17.64M Beat $16.15M Estimate

Beta Bionics Inc - Qtrly Net Sales $17.6 Mln

THOMSON REUTERS

Press Release: Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025

Beta Bionics Inc expected to post a loss of 48 cents a share - Earnings Preview

Beta Bionics to Present at the Bank of America Securities Health Care Conference

Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025

Beta Bionics to Host Investor Event on June 22, 2025

Beta Bionics, Inc. (BBNX) Receives a Buy from Stifel Nicolaus

Stock Track | Beta Bionics (BBNX) Soars 5.21% Following Bank of America's Buy Rating Reiteration

Stock Track | Beta Bionics (BBNX) Soars 5.21% Following Bank of America's Buy Rating Reiteration

Beta Bionics, Inc.: Undervalued Growth Opportunity with Strategic Expansion Plans

Beta Bionics Appoints Gerard Michel as Director

Press Release: Beta Bionics Announces Board Appointment of Gerard Michel

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BBNX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBNX\",,,,,undefined,":{"symbol":"BBNX","market":"US","secType":"STK","nameCN":"Beta Bionics, Inc.","latestPrice":19.08,"timestamp":1749240000000,"preClose":19.55,"halted":0,"volume":583624,"hourTrading":{"tag":"盘后","latestPrice":19.08,"preClose":19.08,"latestTime":"19:48 EDT","volume":1333,"amount":25425.38,"timestamp":1749253710766},"delay":0,"floatShares":26447773,"shares":43356281,"eps":-5.659705,"marketStatus":"Market Closed","change":-0.47,"latestTime":"06-06 16:00:00 EDT","open":19.96,"high":20.19,"low":18.35,"amount":11232005.543848,"amplitude":0.094118,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.659705,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"listingDate":1738213200000,"exchange":"NASDAQ","adjPreClose":19.55,"preHourTrading":{"tag":"盘前","latestPrice":20.52,"preClose":19.55,"latestTime":"09:11 EDT","volume":99,"amount":2006.369937,"timestamp":1749215516498},"postHourTrading":{"tag":"盘后","latestPrice":19.08,"preClose":19.08,"latestTime":"19:48 EDT","volume":1333,"amount":25425.38,"timestamp":1749253710766},"volumeRatio":0.6621030778657779},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBNX\",,,,,undefined,":{"symbol":"BBNX","floatShares":26447773,"roa":"-21.78%","roe":"-81.35%","lyrEps":-8.602584,"volumeRatio":0.6621030778657779,"shares":43356281,"dividePrice":0,"high":20.19,"amplitude":0.094118,"preClose":19.55,"low":18.35,"week52Low":8.89,"pbRate":"2.64","psRate":"11.85","week52High":24.5,"institutionHeld":0,"latestPrice":19.08,"eps":-5.659705,"divideRate":0,"volume":583624,"delay":0,"ttmEps":-5.659705,"open":19.96,"prevYearClose":17,"prevWeekClose":17.24,"prevMonthClose":17.24,"prevQuarterClose":12.24,"fiveDayClose":17.24,"twentyDayClose":14.91,"sixtyDayClose":14.5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBNX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541975880","title":"Chief Commercial Officer Mark Hopman Reports Disposal of Common Shares of Beta Bionics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2541975880","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541975880?lang=en_us&edition=fundamental","pubTime":"2025-06-05 07:30","pubTimestamp":1749079857,"startTime":"0","endTime":"0","summary":"Mark Hopman, the Chief Commercial Officer of Beta Bionics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beta Bionics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL9dwHP0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2541304097","title":"CFO Stephen Feider Reports Disposal of Beta Bionics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2541304097","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541304097?lang=en_us&edition=fundamental","pubTime":"2025-06-05 07:30","pubTimestamp":1749079841,"startTime":"0","endTime":"0","summary":"Stephen Feider, the Chief Financial Officer of Beta Bionics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beta Bionics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL707Wn7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CFO Stephen Feider Reports Disposal of Beta Bionics Inc. Common Shares","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BBNX"],"gpt_icon":0},{"id":"2539276494","title":"Beta Bionics Initiated at Outperform by Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2539276494","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539276494?lang=en_us&edition=fundamental","pubTime":"2025-05-30 23:45","pubTimestamp":1748619900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BBNX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 30, 2025 11:45 ET (15:45 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"gpt_icon":0},{"id":"2539032290","title":"Beta Bionics initiated with a Neutral at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2539032290","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539032290?lang=en_us&edition=fundamental","pubTime":"2025-05-30 09:00","pubTimestamp":1748566813,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst David Roman initiated coverage of Beta Bionics (BBNX) with a Neutral rating and $16 price target as part of a broader researc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beta-bionics-initiated-with-a-neutral-at-goldman-sachs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beta-bionics-initiated-with-a-neutral-at-goldman-sachs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX"],"gpt_icon":0},{"id":"2539299207","title":"Beta Bionics initiated with an Outperform at Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2539299207","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539299207?lang=en_us&edition=fundamental","pubTime":"2025-05-30 05:45","pubTimestamp":1748555110,"startTime":"0","endTime":"0","summary":"Wolfe Research analyst Mike Polark initiated coverage of Beta Bionics (BBNX) with an Outperform rating and $20 price target Published first on TheF...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beta-bionics-initiated-with-an-outperform-at-wolfe-research-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beta-bionics-initiated-with-an-outperform-at-wolfe-research-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX"],"gpt_icon":0},{"id":"2533671756","title":"Beta Bionics reports Q1 EPS (93c), consensus (51c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2533671756","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533671756?lang=en_us&edition=fundamental","pubTime":"2025-05-07 04:38","pubTimestamp":1746563905,"startTime":"0","endTime":"0","summary":"Reports Q1 revenue $17.64M, consensus $16.15M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beta-bionics-reports-q1-eps-93c-consensus-51c?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beta-bionics-reports-q1-eps-93c-consensus-51c?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX"],"gpt_icon":0},{"id":"2533671986","title":"Beta Bionics raises FY25 revenue view to $82M-$87M from $80M-$85M","url":"https://stock-news.laohu8.com/highlight/detail?id=2533671986","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533671986?lang=en_us&edition=fundamental","pubTime":"2025-05-07 04:37","pubTimestamp":1746563845,"startTime":"0","endTime":"0","summary":"Consensus $82.62M. Sees FY25 gross margin 50%-53%. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beta-bionics-raises-fy25-revenue-view-to-82m-87m-from-80m-85m?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beta-bionics-raises-fy25-revenue-view-to-82m-87m-from-80m-85m?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX"],"gpt_icon":0},{"id":"2533662804","title":"Beta Bionics Q1 EPS $(0.93) Misses $(0.46) Estimate, Sales $17.64M Beat $16.15M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533662804","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533662804?lang=en_us&edition=fundamental","pubTime":"2025-05-07 04:21","pubTimestamp":1746562868,"startTime":"0","endTime":"0","summary":"Beta Bionics (NASDAQ:BBNX) reported quarterly losses of $(0.93) per share which missed the analyst consensus estimate of $(0.46) by 102.17 percent. This is a 55.07 percent increase over losses of $(2.07) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45236249/beta-bionics-q1-eps-0-93-misses-0-46-estimate-sales-17-64m-beat-16-15m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"gpt_icon":0},{"id":"2533666195","title":"Beta Bionics Inc - Qtrly Net Sales $17.6 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2533666195","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533666195?lang=en_us&edition=fundamental","pubTime":"2025-05-07 04:02","pubTimestamp":1746561720,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nTUA9L2GYT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BBNX"],"gpt_icon":0},{"id":"2533661620","title":"Press Release: Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2533661620","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533661620?lang=en_us&edition=fundamental","pubTime":"2025-05-07 04:02","pubTimestamp":1746561720,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., May 06, 2025  -- Beta Bionics, Inc. , a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended March 31, 2025 and raised its annual guidance for the year ending December 31, 2025.-- Net sales of $17.6 million, up 36% compared to $12.9 million in the first. -- Durable Medical Equipment  channel net sales of $13.8 million,up 14% compared to $12.1 million in the first quarter of 2024.-- Pharmacy Benefit Plan  channel net sales of $3.8 million, up. 360% compared to $0.8 million in the first quarter of 2024.-- Gross margin of 50.9%, down 482 basis points compared to 55.7% in the. -- Installed customer base (calculated as all new patient starts over a. rolling four-year period) of 19,151 users, up 291% compared to 4,901 in. -- 3,853 new patient starts, up 48% compared to 2,597 new patient starts in. million or negative 96% of sales in the first quarter of 2024.((1) () See \"Non-GAAP Financial M","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BBNX","PBP"],"gpt_icon":0},{"id":"2532803389","title":"Beta Bionics Inc  expected to post a loss of 48 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2532803389","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532803389?lang=en_us&edition=fundamental","pubTime":"2025-05-03 06:48","pubTimestamp":1746226084,"startTime":"0","endTime":"0","summary":"Beta Bionics Inc  expected to post a loss of48cents a share - Earnings Preview Beta Bionics Inc BBNX.OQ BBNX.O is expected to report resultson May 6 for the period ending March 31 2025The Irvine Calif","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250502:nL8N3RA3GQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"gpt_icon":0},{"id":"2532207127","title":"Beta Bionics to Present at the Bank of America Securities Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2532207127","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532207127?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:00","pubTimestamp":1746100800,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., May 01, 2025  -- Beta Bionics, Inc. , a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at the Bank of America Securities Health Care Conference in Las Vegas on Tuesday, May 13, 2025 at 12:35 pm Eastern Time .Media and Public Relations: Karen HynesVice President of Marketingmedia@betabionics.com","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/beta-bionics-present-bank-america-120000209.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B7SZLL34.SGD","LU0306806265.USD","LU0320765646.SGD","LU0106831901.USD","LU0314106906.USD","LU0971096721.USD","LU1791807156.HKD","LU0648001328.SGD","LU1880398471.USD","LU0256863811.USD","LU2129689605.HKD","LU0648000940.SGD","IE00BFXG1179.USD","BK4581","LU1201861249.SGD","LU0149725797.USD","LU1496350171.SGD","LU1201861165.SGD","LU1074936037.SGD","LU2129689514.USD","LU2129689431.USD","IE00BLSP4452.SGD","LU0980610538.SGD","LU2133065610.SGD","LU1880398554.USD","LU0477156797.USD","LU0053666078.USD","LU0130102774.USD","LU1668664300.SGD","LU0052756011.USD","LU1718418525.SGD","LU0170899867.USD","IE00B1BXHZ80.USD","LU0306807586.USD","BK4588","BK4207","LU0098860793.USD","LU0070302665.USD","IE00BKVL7J92.USD","LU1894683348.USD","LU1496350502.SGD","BAC","BBNX","LU0868494617.USD","IE0002270589.USD","BK4559","IE00BLSP4239.USD","BK4504","LU0130103400.USD","LU0787776722.HKD"],"gpt_icon":0},{"id":"2528205097","title":"Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2528205097","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528205097?lang=en_us&edition=fundamental","pubTime":"2025-04-17 04:05","pubTimestamp":1744833900,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., April 16, 2025  -- Beta Bionics, Inc. , a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its first quarter 2025 financial results after the financial markets close on Tuesday, May 6, 2025. In connection with the release, management will host a conference call and concurrent webcast on the same day at 4:30 pm Eastern Time .Media and Public Relations: Karen HynesVice President of Marketingmedia@betabionics.com","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/beta-bionics-announce-first-quarter-200500089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","BBNX"],"gpt_icon":0},{"id":"2526508143","title":"Beta Bionics to Host Investor Event on June 22, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2526508143","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526508143?lang=en_us&edition=fundamental","pubTime":"2025-04-09 19:30","pubTimestamp":1744198200,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., April  09, 2025  (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the development of advanced diabetes management solutions, today announce","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/09/3058311/0/en/Beta-Bionics-to-Host-Investor-Event-on-June-22-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","BK4181","BK4585","BK4082","BK4588","HST","BBNX"],"gpt_icon":0},{"id":"2524208041","title":"Beta Bionics, Inc. (BBNX) Receives a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2524208041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524208041?lang=en_us&edition=fundamental","pubTime":"2025-04-04 19:16","pubTimestamp":1743765373,"startTime":"0","endTime":"0","summary":"In a report released today, Mathew Blackman from Stifel Nicolaus maintained a Buy rating on Beta Bionics, Inc. (BBNX – Research Report), with a pri...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/beta-bionics-inc-bbnx-receives-a-buy-from-stifel-nicolaus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/beta-bionics-inc-bbnx-receives-a-buy-from-stifel-nicolaus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX","BK4082","SF","BK4127"],"gpt_icon":0},{"id":"1143484942","title":"Stock Track | Beta Bionics (BBNX) Soars 5.21% Following Bank of America's Buy Rating Reiteration","url":"https://stock-news.laohu8.com/highlight/detail?id=1143484942","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143484942?lang=en_us&edition=fundamental","pubTime":"2025-04-01 00:28","pubTimestamp":1743438507,"startTime":"0","endTime":"0","summary":"Shares of Beta Bionics, Inc.  are soaring 5.21% in intraday trading on Monday, following a positive analyst report from Bank of America Securities. Analyst Travis Steed reiterated a Buy rating on the stock, signaling continued confidence in the company's growth prospects.Beta Bionics, known for its innovative medical technologies, has been gaining attention from investors and analysts alike. The company's strategic expansion plans and potential market opportunities appear to be driving the optim","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["BBNX"],"gpt_icon":0},{"id":"1100546963","title":"Stock Track | Beta Bionics (BBNX) Soars 5.21% Following Bank of America's Buy Rating Reiteration","url":"https://stock-news.laohu8.com/highlight/detail?id=1100546963","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100546963?lang=en_us&edition=fundamental","pubTime":"2025-04-01 00:28","pubTimestamp":1743438507,"startTime":"0","endTime":"0","summary":"Shares of Beta Bionics, Inc.  are soaring 5.21% in intraday trading on Monday, following a bullish analyst report from Bank of America Securities. The stock's significant uptick comes after analyst Travis Steed reiterated a Buy rating on BBNX, highlighting the company as an undervalued growth opportunity.In the report released early Monday, Steed emphasized Beta Bionics' strategic expansion plans as a key factor in his positive outlook. While specific details of the report were not immediately a","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Beta Bionics (BBNX) Soars 5.21% Following Bank of America's Buy Rating Reiteration","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["BBNX"],"gpt_icon":0},{"id":"2523910757","title":"Beta Bionics, Inc.: Undervalued Growth Opportunity with Strategic Expansion Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2523910757","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523910757?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:15","pubTimestamp":1743419733,"startTime":"0","endTime":"0","summary":"In a report released today, Travis Steed from Bank of America Securities reiterated a Buy rating on Beta Bionics, Inc. (BBNX – Research Report), wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/beta-bionics-inc-undervalued-growth-opportunity-with-strategic-expansion-plans?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/beta-bionics-inc-undervalued-growth-opportunity-with-strategic-expansion-plans?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0070302665.USD","IE0002270589.USD","LU0648001328.SGD","LU1280957306.USD","LU0256863902.USD","LU1894683348.USD","LU0052756011.USD","LU0787776722.HKD","LU0208291251.USD","BK4588","LU1074936037.SGD","LU0310800965.SGD","LU1201861165.SGD","LU0234572021.USD","IE00B1BXHZ80.USD","LU0321505439.SGD","LU0417517546.SGD","LU0320765489.SGD","LU0683600562.USD","LU0306807586.USD","LU0314106906.USD","IE00BLSP4239.USD","BK4581","LU1267930227.SGD","BK4559","LU1366192091.USD","LU1496350171.SGD","LU0130103400.USD","LU1162221912.USD","LU0130102774.USD","LU1363072403.SGD","LU1496350502.SGD","IE00BFXG1179.USD","LU0170899867.USD","LU1718418525.SGD","IE00BZ1G4Q59.USD","LU2129689431.USD","BK4585","LU2133065610.SGD","LU0256863811.USD","LU0128525689.USD","LU2129689514.USD","LU0640476718.USD","LU0098860793.USD","LU0320765646.SGD","LU1894683264.USD","LU0868494617.USD","BAC","BBNX","LU1880398554.USD"],"gpt_icon":0},{"id":"2522853045","title":"Beta Bionics Appoints Gerard Michel as Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2522853045","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522853045?lang=en_us&edition=fundamental","pubTime":"2025-03-28 05:18","pubTimestamp":1743110309,"startTime":"0","endTime":"0","summary":"Beta Bionics, Inc. ( ($BBNX) ) just unveiled an update. On March 26, 2025, Beta Bionics, Inc. announced the appointment of Gerard Michel as a Class...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beta-bionics-appoints-gerard-michel-as-director?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beta-bionics-appoints-gerard-michel-as-director?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2522534031","title":"Press Release: Beta Bionics Announces Board Appointment of Gerard Michel","url":"https://stock-news.laohu8.com/highlight/detail?id=2522534031","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522534031?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:45","pubTimestamp":1743108300,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., March 27, 2025  -- Beta Bionics, Inc. , a pioneering leader in the development of advanced diabetes management solutions, today announced the appointment of Gerard Michel as an independent member of its board of directors, effective March 26, 2025. Mr. Michel is Chief Executive Officer of Delcath Systems , a commercial-stage interventional oncology company.Mr. Michel has over 30 years of experience in the pharmaceutical and medical technology industries across numerous functional areas. Prior to joining Delcath Systems as Chief Executive Officer in 2020, Mr. Michel served as Chief Financial Officer at Vericel Corporation, a biopharmaceutical company. Mr. Michel also served as Chief Financial Officer and Vice President, Corporate Development at Biodel, Inc. from November 2007 to May 2014, and Chief Financial Officer and Vice President of Corporate Development at NPS Pharmaceuticals Inc. from August 2002 to November 2007. Previously, Mr. Michel was a Principal at Booz All","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4082"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":51,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBNX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-06","symbol":"BBNX","fiscalQuarterEnding":"2025/03","expectedEps":-0.51,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-0.52},{"market":"US","date":"2025-03-25","symbol":"BBNX","fiscalQuarterEnding":"2024/12","expectedEps":-0.42,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742875200000,"reportTimeType":"post","actualEps":-1.82}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBNX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.25,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":8,"updateTime":1748577600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BBNX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BBNX","date":"2025-06-06","current":-11.944468,"percent":0.348315,"low":-18.401318,"twenty":-15.890764,"median":-10.161718,"eighty":-8.656151,"high":-3.90273,"avg":-11.499031,"sd":3.483161,"marketCap":847615293},"quantilePoints":[{"date":"2025-01-31","current":-18.262207,"twenty":-16.058067,"median":-12.751858,"eighty":-7.442381,"marketCap":1013479428},{"date":"2025-02-07","current":-18.125788,"twenty":-18.207639,"median":-17.701026,"eighty":-14.679009,"marketCap":1005908733},{"date":"2025-02-14","current":-16.797439,"twenty":-18.139689,"median":-17.569735,"eighty":-16.871579,"marketCap":932190666},{"date":"2025-02-21","current":-16.117818,"twenty":-18.053192,"median":-17.39983,"eighty":-16.806707,"marketCap":894474446},{"date":"2025-02-28","current":-15.376414,"twenty":-17.738096,"median":-16.901699,"eighty":-15.527784,"marketCap":853329479},{"date":"2025-03-07","current":-13.754592,"twenty":-17.625341,"median":-16.797439,"eighty":-14.919215,"marketCap":763324863},{"date":"2025-03-14","current":-10.843036,"twenty":-17.540388,"median":-16.156433,"eighty":-12.952405,"marketCap":601745147},{"date":"2025-03-21","current":-12.117325,"twenty":-17.418365,"median":-15.88613,"eighty":-12.19996,"marketCap":672463060},{"date":"2025-03-28","current":-10.030495,"twenty":-17.316422,"median":-15.090664,"eighty":-11.612243,"marketCap":549229802},{"date":"2025-04-04","current":-8.526317,"twenty":-16.978156,"median":-13.955389,"eighty":-11.224551,"marketCap":466867006},{"date":"2025-04-11","current":-8.462983,"twenty":-16.936452,"median":-12.789848,"eighty":-9.75816,"marketCap":463399099},{"date":"2025-04-17","current":-8.660901,"twenty":-16.843777,"median":-12.343221,"eighty":-9.270489,"marketCap":474236309},{"date":"2025-04-25","current":-8.755902,"twenty":-16.843777,"median":-12.117325,"eighty":-8.660901,"marketCap":479438170},{"date":"2025-05-02","current":-8.819236,"twenty":-16.797439,"median":-11.630778,"eighty":-8.660901,"marketCap":482906077},{"date":"2025-05-09","current":-9.109566,"twenty":-16.202771,"median":-11.468596,"eighty":-8.660901,"marketCap":646442149},{"date":"2025-05-16","current":-8.41306,"twenty":-16.195048,"median":-11.020664,"eighty":-8.526317,"marketCap":597015989},{"date":"2025-05-23","current":-9.476148,"twenty":-16.117818,"median":-10.030495,"eighty":-8.550067,"marketCap":672455918},{"date":"2025-05-30","current":-9.384503,"twenty":-15.951002,"median":-9.677769,"eighty":-8.619734,"marketCap":665952476},{"date":"2025-06-06","current":-11.944468,"twenty":-15.890764,"median":-10.161718,"eighty":-8.656151,"marketCap":847615293}],"updateTime":1749400965899}}}